+91
By proceeding, you agree to all T&C*
Didn't receive the code? Resend
KRONOX

Kronox Lab Sciences Share Price

 

 

Kronox Lab Sciences live price: ₹147.11. It opened at ₹146 vs previous close ₹147; intraday high/low: ₹150/₹146. The 50 & 200 DMA stand at ₹137.03/₹138.79.

Kronox Lab Sciences Performance

  • Today's Low
  • ₹146
  • Today's High
  • ₹150
  • 52 Week Low
  • ₹96
  • 52 Week High
  • ₹207
  • Open Price₹146
  • Previous Close₹147
  • Volume38,835
  • 50 DMA₹137.03
  • 100 DMA₹134.51
  • 200 DMA₹138.79

Kronox Lab Sciences Chart

Investment Returns

  • Over 1 Month + 7.47%
  • Over 3 Month + 40.73%
  • Over 6 Month + 2.59%
  • Over 1 Year -11.64%

Smart Investing Starts Here Start SIP with Kronox Lab Sciences for Steady Growth!

Invest Now

Kronox Lab Sciences Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 19.8
  • PEG Ratio
  • 2.4
  • Market Cap Cr
  • 546
  • P/B Ratio
  • 4.7
  • Average True Range
  • 6.5
  • EPS
  • 7.45
  • Dividend Yield
  • 0.3
  • MACD Signal
  • 3.67
  • RSI
  • 57.37
  • MFI
  • 69.59

Latest Stock News Updates

Kronox Lab shares got listed at 21% premium. What should investors do?

Kronox Lab Sciences had a decent listing at the bourses, falling short of expectations due to market volatility. Analysts praise its strong position in specialty fine chemicals sector.

Kronox Lab Sciences Financials

Kronox Lab Sciences Technicals

EMA & SMA

Current Price
₹147.11
+ 0.09 (0.06%)
pointer
  • Bearish Moving Average 2
  • Bullish Moving Average 14
  • 20 Day
  • ₹143.20
  • 50 Day
  • ₹137.00
  • 100 Day
  • ₹134.50
  • 200 Day
  • ₹138.80

Resistance and Support

147.51 Pivot Speed
  • R3 153.51
  • R2 151.64
  • R1 149.38
  • S1 145.25
  • S2 143.38
  • S3 141.12

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Kronox Lab Sciences Ltd has an operating revenue of Rs. 101.22 Cr. on a trailing 12-month basis. An annual revenue growth of 4% is not great, Pre-tax margin of 37% is great, ROE of 23% is exceptional. The company has a reasonable debt to equity of 1%, which signals a healthy balance sheet. The stock from a technical standpoint is comfortably placed above its key moving averages, around 10% and 8% from 50DMA and 200DMA. It has recently broken out of a base in its weekly chart and is trading around 0% from the pivot point (which is the ideal buying range for a stock). From an O'Neil Methodology perspective, the stock has an EPS Rank of 79 which is a FAIR score but needs to improve its earnings, a RS Rating of 70 which is FAIR indicating the recent price performance, Buyer Demand at B+ which is evident from recent demand for the stock, Group Rank of 41 indicates it belongs to a fair industry group of Chemicals-Specialty and a Master Score of C is fair but needs to improve. Overall, the stock has mediocre earnings and technical strength, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Kronox Lab Sciences Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2026-05-21 Audited Results & Final Dividend
2026-05-20 Audited Results & Final Dividend
2026-02-14 Quarterly Results
2025-11-11 Quarterly Results
2025-08-11 Quarterly Results
Date Purpose Remarks
2025-08-08 FINAL Rs.0.50 per share(5%)Final Dividend
View Kronox Lab Sciences Dividend History Arrow

Kronox Lab Sciences Shareholding Pattern

74.21%
0.08%
20.98%
4.73%

Kronox Lab Sciences FAQs

Kronox Lab Sciences share price is ₹147 As on 24 June, 2026 | 21:01

The Market Cap of Kronox Lab Sciences is ₹545.8 Cr As on 24 June, 2026 | 21:01

The P/E ratio of Kronox Lab Sciences is 19.8 As on 24 June, 2026 | 21:01

The PB ratio of Kronox Lab Sciences is 4.7 As on 24 June, 2026 | 21:01

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23